Wilmer Cutler Pickering Hale and Dorr advised Eliem Therapeutics on the deal, and Cooley advised Tenet Medicines. Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced that it had entered into...
You must be a Standard 1 Year member to access this content.
Cooley advised Inscripta on the deal. Inscripta, a global leader in genome engineering technology, announced its acquisition of Infinome Biosciences and Sestina Bio. These acquisitions advance Inscripta’s...
You must be a Standard 1 Year member to access this content.
Cooley advised Velocity Global on the deal. Velocity Global, a leading provider of global talent solutions, announced its $400 million Series B financing round. With the fundraise,...
You must be a Standard 1 Year member to access this content.
